Journal article icon

Journal article

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs

Abstract:
The proliferation of antimalarial drug trials in the last ten years provides the opportunity to launch a concerted global surveillance effort to monitor antimalarial drug efficacy. The diversity of clinical study designs and analytical methods undermines the current ability to achieve this. The proposed World Antimalarial Resistance Network (WARN) aims to establish a comprehensive clinical database from which standardised estimates of antimalarial efficacy can be derived and monitored over time from diverse geographical and endemic regions. The emphasis of this initiative is on five key variables which define the therapeutic response. Ensuring that these data are collected at the individual patient level in a consistent format will facilitate better data management and analytical practices, and ensure that clinical data can be readily collated and made amenable for pooled analyses. Such an approach, if widely adopted will permit accurate and timely recognition of trends in drug efficacy. This will guide not only appropriate interventions to deal with established multidrug resistant strains of malaria, but also facilitate prompt action when new strains of drug resistant plasmodia first emerge. A comprehensive global database incorporating the key determinants of the clinical response with in vitro, molecular and pharmacokinetic parameters will bring together relevant data on host, drug and parasite factors that are fundamental contributors to treatment efficacy. This resource will help guide rational drug policies that optimize antimalarial drug use, in the hope that the emergence and spread of resistance to new drugs can be, if not prevented, at least delayed.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1186/1475-2875-6-119

Authors

More by this author
Institution:
"Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia", "University of Oxford"
Department:
Medical Sciences Division - Clinical Vaccinology and Tropical Medicine,Centre for (CCVTM)
Role:
Author
More by this author
Institution:
University of California, San Francisco, CA, USA
Department:
Department of Medicine
Role:
Author
More by this author
Institution:
Epicentre, Paris, France
Role:
Author
More by this author
Institution:
University of Cape Town, South Africa
Department:
Division of Clinical Pharmacology,Department of Medicine
Role:
Author
More by this author
Institution:
ALERTAsia Foundation, Eijkman Institute for Molecular Biology, Jakarta Pusat, Indonesia
Role:
Author


Publisher:
BioMed Central
Journal:
Malaria Journal More from this journal
Volume:
6
Article number:
119
Publication date:
2007-09-01
Edition:
Publisher's version
DOI:
ISSN:
1475-2875


Language:
English
Keywords:
Subjects:
UUID:
uuid:faa63dab-797a-47a7-8c91-d1d890ac46f1
Local pid:
ora:5225
Deposit date:
2011-04-08
ARK identifier:

Terms of use


Views and Downloads

Views and downloads will return soon






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP